Connect with us


Bayer Promotes Eye Health Awareness Among Diabetic Patients




It’s called “Shifting the Needle.”

Pharmaceutical giant Bayer is promoting eye health awareness among diabetic patients through a new advocacy campaign.

The effort follows a Bayer-funded study that found that diabetic patients “are waiting too long to discuss vision problems with their doctors,” FiercePharma reports.

The effort is geared toward both patients and healthcare professionals. Bayer sells the drug Eylea to treat diabetic retinopathy in people who have diabetic macular edema, FiercePharma notes.

The research, called the DR Barometer Study, involved the International Federation on Ageing, the International Agency for the Prevention of Blindness and the International Diabetes Federation.


According to the DR Barometer website: “A growing of voices in the fields of aging, diabetes and vision has joined in solidarity under the banner of DR Barometer: Shifting the Needle to call for urgent policy actions for diabetes-related eye health.”

Read more at FiercePharma


See What’s Possible with EssilorLuxottica 360

When you have 360 degrees of support, you can grow your independent practice with confidence. When that support comes from industry leaders with a proven track record of providing partnership opportunities which help independent practices maximize their success – well, the possibilities are endless. From increased visibility through cutting-edge marketing to enhanced patient experiences leading to a better capture rate and everything in between, see what’s possible with EssilorLuxottica 360. Learn more at Powering your practice. Empowering you.

Promoted Headlines





Get the most important news and business ideas for eyecare professionals every weekday from INVISION.


Most Popular